GREENWAVE TECHNOLOGY SOLUTIO (GWAV)

US57630J4031 - Common Stock

0.6989  +0.06 (+9.29%)

Premarket: 0.6994 +0 (+0.07%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to GWAV. GWAV was compared to 83 industry peers in the Commercial Services & Supplies industry. GWAV may be in some trouble as it scores bad on both profitability and health. GWAV has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year GWAV has reported negative net income.
GWAV had a negative operating cash flow in the past year.
GWAV had negative earnings in 4 of the past 5 years.
In the past 5 years GWAV always reported negative operating cash flow.

1.2 Ratios

GWAV has a worse Return On Assets (-123.92%) than 96.39% of its industry peers.
Looking at the Return On Equity, with a value of -168.15%, GWAV is doing worse than 86.75% of the companies in the same industry.
Industry RankSector Rank
ROA -123.92%
ROE -168.15%
ROIC N/A
ROA(3y)-73.03%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 37.21%, GWAV is in the better half of the industry, outperforming 62.65% of the companies in the same industry.
GWAV's Gross Margin has declined in the last couple of years.
GWAV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-25.95%
GM growth 5Y-16.49%

3

2. Health

2.1 Basic Checks

GWAV does not have a ROIC to compare to the WACC, probably because it is not profitable.
GWAV has less shares outstanding than it did 1 year ago.
GWAV has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, GWAV has a worse debt to assets ratio.

2.2 Solvency

GWAV has an Altman-Z score of -9.35. This is a bad value and indicates that GWAV is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -9.35, GWAV is not doing good in the industry: 93.98% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.09 indicates that GWAV is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.09, GWAV is in the better half of the industry, outperforming 75.90% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z -9.35
ROIC/WACCN/A
WACC7.13%

2.3 Liquidity

A Current Ratio of 1.52 indicates that GWAV should not have too much problems paying its short term obligations.
GWAV has a Current ratio (1.52) which is comparable to the rest of the industry.
A Quick Ratio of 1.36 indicates that GWAV should not have too much problems paying its short term obligations.
GWAV has a Quick ratio (1.36) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 1.36

3

3. Growth

3.1 Past

GWAV shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.64%.
The Revenue has been growing slightly by 3.88% in the past year.
The Revenue has been growing by 346.94% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-8.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.9%
Revenue 1Y (TTM)3.88%
Revenue growth 3Y1427.89%
Revenue growth 5Y346.94%
Sales Q2Q%3.98%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

GWAV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

GWAV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GREENWAVE TECHNOLOGY SOLUTIO

NASDAQ:GWAV (12/18/2024, 8:26:38 PM)

Premarket: 0.6994 +0 (+0.07%)

0.6989

+0.06 (+9.29%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-12 2024-11-12
Earnings (Next)N/A N/A
Inst Owners4.23%
Inst Owner Change-26.32%
Ins Owners15.41%
Ins Owner Change48.61%
Market Cap15.64M
AnalystsN/A
Price TargetN/A
Short Float %20.14%
Short Ratio0.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.46
P/FCF N/A
P/OCF N/A
P/B 0.31
P/tB 0.47
EV/EBITDA N/A
EPS(TTM)-286.8
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.09
FCFYN/A
OCF(TTM)-0.63
OCFYN/A
SpS1.52
BVpS2.29
TBVpS1.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -123.92%
ROE -168.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.21%
FCFM N/A
ROA(3y)-73.03%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-25.95%
GM growth 5Y-16.49%
F-Score3
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 151.86%
Cap/Sales 30.67%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.52
Quick Ratio 1.36
Altman-Z -9.35
F-Score3
WACC7.13%
ROIC/WACCN/A
Cap/Depr(3y)243.33%
Cap/Depr(5y)N/A
Cap/Sales(3y)8.38%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.88%
Revenue growth 3Y1427.89%
Revenue growth 5Y346.94%
Sales Q2Q%3.98%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-56.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-202.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-235.79%
OCF growth 3YN/A
OCF growth 5YN/A